Rare diseases
Investigational molecules
Locations
Back to Italy2 209 clinical trials in Rome, Italy across 15 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of Tofacitinib for Children with Moderate to Severe Ulcerative Colitis
ItalyStudy of Cemiplimab Compared to Placebo After Surgery and Radiation for Patients with High-Risk Skin Squamous Cell Carcinoma
ItalyLong-term Safety and Efficacy Study of Onasemnogene Abeparvovec in Patients with Spinal Muscular Atrophy
ItalyStudy on the Effectiveness and Tolerability of Ofatumumab Compared to a Drug Combination for Patients with Newly Diagnosed Relapsing Multiple Sclerosis
ItalyItalyItalyStudy on the Effectiveness of Durvalumab, Tremelimumab, and Chemotherapy in Patients with Advanced Bladder or Urinary System Cancer
ItalyStudy on the Effectiveness and Safety of Olorofim vs. Liposomal Amphotericin B for Patients with Invasive Aspergillosis
ItalyStudy on Vimseltinib for Patients with Tenosynovial Giant Cell Tumor
ItalyStudy of Belzutifan and Palbociclib for Patients with Advanced Renal Cell Carcinoma
ItalyItalyStudy on Extended Access to Momelotinib for Patients with Myelofibrosis
ItalyThe busiest research cities in the country
What the registry says about research in the country
Clinical studies focusing on Idiopathic Pulmonary Fibrosis and COPD, evaluating new therapeutic approaches for improving lung function and reducing disease progression.
Advanced research includes novel antibody treatments and preventive measures for respiratory infections.
Innovative trials targeting metastatic colorectal cancer, gastric cancer, and acute myeloid leukemia, exploring new treatment combinations and targeted therapies.
Studies focus on improving response rates and survival outcomes in various cancer types.
Research into Parkinson's disease and acute ischemic stroke, investigating novel therapeutic approaches and neuroprotective strategies.
Studies aim to improve neurological outcomes and patient quality of life.
Clinical trials examining Immune Thrombocytopenia and Hidradenitis Suppurativa, testing new therapeutic agents for immune-mediated conditions.
Research focuses on improving treatment outcomes in challenging immune disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
